phthalonic acid has been researched along with Glaucoma in 1 studies
*Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Menabuoni, L; Mincione, F; Scozzafava, A; Supuran, CT | 1 |
1 other study(ies) available for phthalonic acid and Glaucoma
| Article | Year |
|---|---|
Carbonic anhydrase inhibitors: topically acting antiglaucoma sulfonamides incorporating phthaloyl and phthalimido moieties.
Topics: Administration, Topical; Animals; Buffers; Carbonic Anhydrase Inhibitors; Cattle; Cornea; Glaucoma; Humans; Hydrogen-Ion Concentration; Intraocular Pressure; Male; Osmolar Concentration; Phthalic Acids; Phthalimides; Rabbits; Solubility; Sulfonamides | 2001 |